2018
DOI: 10.1177/1078155218778106
|View full text |Cite
|
Sign up to set email alerts
|

User acceptance of an app-based adherence intervention: Perspectives from patients taking oral anticancer medications

Abstract: Background Widespread adoption by patients is imperative for the success of app-based interventions for enhancing adherence to oral anticancer medications. Patients' attitudes and beliefs should be evaluated to understand determinants of their acceptance and adoption of such interventions. Objective To identify factors that influence cancer patients' intention to adopt an app-based system for enhancing oral anticancer medication adherence. Methods This study was conducted as part of the usability evaluation of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 34 publications
0
27
0
Order By: Relevance
“…Follow-up may be achieved through direct interactions with treating clinicians, interactions with other members of a multidisciplinary team (e.g., nurses and pharmacists), or through web-based applications [22][23][24][25]. Notably, recent surveys indicate that patients taking oral anticancer medications are interested in technologies to help them manage their treatment, such as pill reminders and apps that allow reporting of symptoms to physicians [24,26]. Electronic medication reminders have been shown to encourage adherence [27,28], and the ability to report symptoms to clinicians or other healthcare team members via the internet has been associated with improvements in patient quality of life, better management of AEs, decreased hospitalizations, and longer overall survival [27,[29][30][31][32].…”
Section: General Advice For Dosing and Delivery Of Rucaparibmentioning
confidence: 99%
See 1 more Smart Citation
“…Follow-up may be achieved through direct interactions with treating clinicians, interactions with other members of a multidisciplinary team (e.g., nurses and pharmacists), or through web-based applications [22][23][24][25]. Notably, recent surveys indicate that patients taking oral anticancer medications are interested in technologies to help them manage their treatment, such as pill reminders and apps that allow reporting of symptoms to physicians [24,26]. Electronic medication reminders have been shown to encourage adherence [27,28], and the ability to report symptoms to clinicians or other healthcare team members via the internet has been associated with improvements in patient quality of life, better management of AEs, decreased hospitalizations, and longer overall survival [27,[29][30][31][32].…”
Section: General Advice For Dosing and Delivery Of Rucaparibmentioning
confidence: 99%
“…Although generally low grade, diarrhea often occurs when patients initiate rucaparib (median time to onset [95% CI], 29 [17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35] days) [21]. Clinicians should exclude other causes (e.g.…”
Section: Diarrheamentioning
confidence: 99%
“…The primary outcome will be to assess the improvement in treatment adherence 17. The secondary outcomes will be to assess the improvement in overall survival and life expectancy, improved quality of life and control of cancer-related symptoms 9–11…”
Section: Methods and Analysismentioning
confidence: 99%
“…A variety of education, symptom management and reminder-based interventions, which involve face-to-face interactions, phone calls and texting short message service (SMS) have been developed and tested. However, the effectiveness of these interventions remains inconclusive 9–11…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation